June 23

Galectin Therapeutics buries bad news in the hype of a combination cancer drug trial

first_img What is it? Senior Writer, Biotech Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He’s also a co-host of “The Readout LOUD” podcast. Melanoma cells NIH [email protected] Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED Adam Feuerstein Galectin Therapeutics buries bad news in the hype of a combination cancer drug trial Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. @adamfeuerstein Log In | Learn More center_img Adam’s Take STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. GET STARTED By Adam Feuerstein Sept. 21, 2018 Reprints About the Author Reprints Galectin Therapeutics (GALT) says new clinical trial data disclosed Thursday suggest its experimental cancer drug improves the efficacy of Merck’s blockbuster immunotherapy therapy Keytruda when the two drugs are used together to treat patients with advanced melanoma.No, the new Galectin data — what little there are — show no such thing. It’s more reasonable to conclude these new data show Galectin’s drug to be a placebo. What’s included? Tags biotechnologycancerdrug developmentSTAT+last_img

Tags: , , , , , , , , , , ,
Copyright 2021. All rights reserved.

Posted June 23, 2021 by admin in category "ixrbaptme

Leave a Reply

Your email address will not be published. Required fields are marked *